3rd Annual Meeting Programme

VALIDATE 3rd Annual Meeting Programme

Tuesday 1 October 2019 (full day)

[0900-1000  Closed Network Management Board Meeting in Boardroom 2]

In The Grand Hall - All delegates

0915   Registration and tea/coffee

1010   Prof Helen McShane

  VALIDATE Director, University of Oxford

  Welcome

1020   Samantha Vermaak

  VALIDATE Network Manager, University of Oxford

  An update on VALIDATE at the end of our second year

1040   Talks by most recently funded round #3 projects:

1040   Prof Myron Christodoulides

   University of Southampton, UK

            Protective efficacy of conserved Leishmania hypothetical proteins against visceral leishmaniasis (P019)

  1053   Dr Barbara Kronsteiner-Dobramysl

   University of Oxford, UK

             Metabolic reprogramming of skin microenvironment for improved BCG vaccine efficacy (P020)

1106   Dr Sasha Larsen

  IDRI, USA

           Development of an RNA based vaccine against Mycobacterium tuberculosis (P021)

1119   Dr Elena Stylianou

  University of Oxford, UK

            Developing a mouse model of diabetes to evaluate vaccines for TB and melioidosis (P022)

1132   Dr Julen Tomás Cortázar

  University College Dublin, Ireland

  Elucidating the T-cell epitopes and T-cells responses of two B.pseudomallei vaccine agents (P023)

1145   Emilie Karafillakis

  LSHTM, UK

  Monitoring and addressing challenging risks, rumours and reputations across the GCRF Vaccinology Networks

1200   Lunch

1300   Talks by funded round #1 projects (all now finished):

1300   Sally Hayward  

  SGUL/LSHTM, UK

  Enhancing BCG efficacy: the Social Technology Lab Initiative (P002)

1320   Dr Javier Salguero Bodes

  Public Health England (PHE), UK

  The effect of BCG vaccination in immune responses against visceral leishmaniasis in a natural (canine) model of infection (P003)

1340   Asst Prof Steve Smith

  LSHTM, UK

  How do functional and metabolic characteristics of trained monocytes affect their anti-bacterial activity? (P004)

1400   Dr Panjaporn Chaichana

  MORU, Thailand

  Establishment of a functional assay panel to evaluate the role of antibodies in defence against melioidosis and tuberculosis (P007)

1420   Dr Rajko Reljic

  SGUL, UK

  Overcoming innate immune tolerance in the respiratory tract for optimal vaccine design (P009)

1440   Dr Bernardo Villarreal-Ramos

  APHA, UK

  Natural variation of the bovine lymph node microenvironment and its possible effect on BCG immunogenicity (P011)

1500   Tea/coffee break

1530   Keynote speech: 

  Affiliate Prof Rhea Coler

  IDRI, USA

  Novel TB and Leprosy Vaccines: from the lab bench to clinical trials (an industry perspective)

1730   Wembley Stadium private tour

 VALIDATE has organised a 'behind the scenes' tour of the world-class Wembley Stadium for those who are interested.Highlights include the England dressing room, the press conference facilities, the Royal Box and the players' tunnel. This is at VALIDATE's costs. Find out more about the stadium and it's history in UK sport and entertainment, including hosting the 2012 London Olympics and FA Cup Finals, here.

1900   Dinner

  VALIDATE will provide a 'No host' dinner for delegates who would like to participate and network further with other members. This will be at each delegates own cost.

Wednesday 2 October 2019 (morning) - The Grand Hall

0830   Tea/coffee

0900   Talks by funded round #2 projects (which are close to finishing):

0900   Dr Mohamed Osman

   University of York, UK

  Identification of Leishmania donovani and Mycobacterium tuberculosis - derived proteins on the surface of infected macrophages that are associated with ADCC induction (P012)

0920   Prof Susie Dunachie

  University of Oxford, UK

  Vaccines to target people with diabetes: characterising the pathways of immune response to M.tuberculosis and B.pseudomallei in people with diabetes compared to non-diabetes (P016)

0940   VALIDATE Fellow talks

0940   Prof Samantha Sampson on behalf of Dr Jomien Mouton

  Stellenbosch University, South Africa

  Identification of latency associated antigens and biosignatures associated with Mycobacterium tuberculosis

0955  Dr Rachel Tanner

University of Oxford, UK

Characterising the BCG-induced antibody response to inform the design of improved vaccines against M.tuberculosis, M.leprae and M.bovis

1010   Tea/coffee break

1040   Research Funder talks - aiming to help members find future funding opportunities

1040   Prof Helen Fletcher

  UKRI/LSHTM, UK

           Global Challenges Research Fund (GCRF) and Newton Fund

1100   Dr Peter Hart

  Wellcome, UK

  Wellcome Vaccines Funding

1120   Dr Martin Broadstock

  Medical Research Council (MRC), UK

  MRC Funding opportunities

1140   Prof Helen McShane

  VALIDATE Director, University of Oxford

  Annual Meeting wrap-up

1200   Lunch (where you will be joined by the open Science Conference delegates. The day continues into the VALIDATE-BSI 2019 Scientific Conference 'Vaccine Development for Neglected Intracellular Pathogens.'

To register for the 3rd VALIDATE Annual Meeting, visit our Conference and Annual Meeting webpage. Registration closes 6th September.

Printable version of the Programme:

3rd VALIDATE Annual Meeting Programme.pdf

3rd VALIDATE Annual Meeting Programme.pdf